新生儿维生素B12缺乏筛查可降低婴儿期症状性缺乏风险
本研究通过德国儿科监测单位开展全国性监测,前瞻性收集2021至2022年<12月龄维生素B12缺乏病例,比较经新生儿筛查发现与出现症状后诊断的婴儿特征。结论提示新生儿维生素B12缺乏筛查可能使婴儿期症状性缺乏风险降低约四倍。
要点
- 未筛查婴儿症状性缺乏报告频率是筛查婴儿的4倍(OR 4.12)。
- 非筛查组中位4月龄出现肌张力低下、贫血、发育迟缓等症状。
核心结论
- 新生儿维生素B12缺乏筛查可能使婴儿期症状性维生素B12缺乏风险降低约四倍。
研究设计与样本
- 与德国儿科监测单位合作的全国性监测研究,2021至2022年前瞻性收集<12月龄维生素B12缺乏病例。
- 共分析61例维生素B12缺乏病例,其中经新生儿筛查发现31例,出现症状后诊断30例。
主要发现
- 非筛查组中位4月龄就诊,表现为肌张力低下(68%)、贫血(58%)、发育迟缓(44%)、小头畸形(30%)和惊厥(12%)。
临床怎么用
- 儿科医生应关注新生儿维生素B12缺乏筛查结果,对筛查阳性婴儿及早评估和干预。
- 对未筛查婴儿,若出现肌张力低下、贫血、发育迟缓、小头畸形或惊厥,需警惕维生素B12缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitamin B12 deficiency (VitB12D) might cause neuro-developmental impairment in the first year of life. Newborn screening (NBS) for VitB12D was shown to be technically feasible and early treated infants developed favorably. This study aims to evaluate the impact of NBS in prevention of symptomatic infantile VitB12D. METHODS: In a nationwide surveillance study in cooperation with the German Pediatric Surveillance Unit, incident cases with VitB12D (<12 months of age) were prospectively collected from 2021 to 2022. RESULTS: In total, 61 cases of VitB12D reported to German Pediatric Surveillance Unit were analyzed, either identified by NBS (N = 31) or diagnosed after the onset of suggestive symptoms (non-NBS; N = 30). Ninety percent of the infants identified by NBS were still asymptomatic, whereas the non-NBS cohort presented at median 4 month of age with muscular hypotonia (68%), anemia (58%), developmental delay (44%), microcephalia (30%), and seizures (12%). Noteworthy, symptomatically diagnosed VitB12D in the first year of life was reported 4 times more frequently in infants who did not receive NBS for neonatal VitB12D (14 in 584 800) compared with those screened for VitB12D as newborns (4 in 688 200; Fisher's Exact Test, odds ratio 4.12 [95% confidence interval: 1.29-17.18], P = .008). The estimated overall cumulative incidence was 1:9600 newborns per year for neonatal VitB12D and 1:17 500 for symptomatic infantile VitB12D. CONCLUSIONS: NBS for neonatal VitB12D may lead to a fourfold risk reduction of developing symptomatic VitB12D in the first year of life compared with infants without NBS.
引用
- Mütze U, Gleich F, Haas D, et al. Vitamin B12 Deficiency Newborn Screening. Pediatrics. 2024. PMID: 39040028. doi:10.1542/peds.2023-064809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。